Spanish authorities have dismantled a major illegal aesthetic medicine network, arresting nine individuals and seizing over 10,000 doses of botulinum toxin and 200 vials of hyaluronic acid. The operation, led by the Guardia Civil across four provinces, highlights serious supply-chain risks for overseas buyers and distributors regarding unauthorized imports, cold-chain failures, and unregulated clinic practices.
Operation details
The Guardia Civil conducted seven coordinated raids in Bizkaia, Barcelona, Las Palmas, and Asturias, targeting a network allegedly importing and distributing unauthorized aesthetic medical products. The investigation began in March 2025 after suspicious packages were detected at Foronda Airport in Vitoria-Gasteiz. Shipments, many from South Korea and Vietnam, entered Spain without required health authorizations. Two additional individuals remain under investigation.
Seized products and health concerns
Authorities confiscated approximately 10,000 doses of botulinum toxin, more than 200 vials of hyaluronic acid, and other pharmaceutical products, including diabetes medication allegedly misused for weight loss. Officials raised particular concern over failure to maintain the cold chain for injectable aesthetic treatments, warning that improper storage can alter product stability and effectiveness, increasing patient risks.
Regulatory and channel signals
The case underscores the importance of regulatory compliance for aesthetic product importers and distributors. Products were brought into Spain without meeting medicine import regulations or strict storage and transport requirements. Both unqualified individuals and some licensed professionals were allegedly involved in administering unauthorized products in hair salons, beauty centers without medical licenses, and private homes. Arrests were made in Bilbao, Basauri, Galdakao, Barakaldo, L'Hospitalet de Llobregat, Cornellà de Llobregat, Avilés, Carrizal, and Vecindario.
What buyers should watch
For overseas importers, distributors, and clinic buyers, this case highlights critical supply-chain risks: verify that all aesthetic injectables are sourced through authorized channels with proper documentation and cold-chain compliance. Legitimate clinics should provide clear product sourcing information, maintain medical records, and operate in authorized medical facilities. Avoid suppliers offering unusually low prices or relying on informal channels, as these may indicate unauthorized or unsafe products. Authorities recovered over €115,000 in suspected illegal proceeds.
Source: Read the original report | Published: May 31, 2026